Symbol:
Cux2
Name:
cut-like homeobox 2
RGD ID:
1305967
Description:
Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in several processes, including positive regulation of nervous system development; regulation of gene expression; and short-term memory. Predicted to act upstream of or within negative regulation of DNA-templated transcription. Predicted to be active in nucleus. Human ortholog(s) of this gene implicated in developmental and epileptic encephalopathy 67. Orthologous to human CUX2 (cut like homeobox 2); INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
cut-like 2; cut-like 2 (Drosophila); Cutl2; homeobox protein cut-like 2; LOC288665
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
CUX2 (cut like homeobox 2) HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther
Mus musculus (house mouse):
Cux2 (cut-like homeobox 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Cux2 (cut like homeobox 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
CUX2 (cut like homeobox 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
CUX2 (cut like homeobox 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Cux2 (cut like homeobox 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
CUX2 (cut like homeobox 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
CUX2 (cut like homeobox 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Cux2 (cut like homeobox 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
ALKBH2 (alkB homolog 2, alpha-ketoglutarate dependent dioxygenase) HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
CUX2 (cut like homeobox 2)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Cux2 (cut-like homeobox 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cux2b (cut-like homeobox 2b)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
COY1
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Caenorhabditis elegans (roundworm):
ceh-44
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Drosophila melanogaster (fruit fly):
ct
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
cux2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 12 40,168,402 - 40,368,303 (+) NCBI GRCr8 mRatBN7.2 12 34,507,723 - 34,707,581 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 12 34,520,959 - 34,705,806 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 12 35,693,412 - 35,878,823 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 12 36,304,624 - 36,490,037 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 12 35,357,113 - 35,542,505 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 12 40,016,774 - 40,221,067 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 12 40,018,937 - 40,219,291 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 12 41,893,143 - 42,092,024 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 12 35,850,093 - 35,910,414 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 12 35,727,879 - 35,773,518 (+) NCBI Celera 12 36,188,363 - 36,371,360 (+) NCBI Celera Cytogenetic Map 12 q16 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Cux2 Rat 17alpha-ethynylestradiol increases expression ISO Cux2 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CUX2 mRNA CTD PMID:17942748 Cux2 Rat 17alpha-ethynylestradiol multiple interactions ISO Cux2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUX2 mRNA CTD PMID:17942748 Cux2 Rat 17beta-estradiol multiple interactions ISO CUX2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of CUX2 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of CUX2 mRNA CTD PMID:17404688 and PMID:30165855 Cux2 Rat 17beta-estradiol decreases expression ISO Cux2 (Mus musculus) 6480464 Estradiol results in decreased expression of CUX2 mRNA CTD PMID:39298647 Cux2 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CUX2 mRNA CTD PMID:32145629 Cux2 Rat 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO Cux2 (Mus musculus) 6480464 Dihydrotestosterone results in decreased expression of CUX2 mRNA CTD PMID:17023530 Cux2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cux2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CUX2 mRNA CTD PMID:21889950 and PMID:24058054 Cux2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cux2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CUX2 mRNA CTD PMID:28922406 Cux2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cux2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CUX2 mRNA CTD PMID:26290441 and PMID:37172768 Cux2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CUX2 mRNA CTD PMID:21215274 Cux2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO CUX2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of CUX2 mRNA CTD PMID:22298810 Cux2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO CUX2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CUX2 mRNA CTD PMID:19692669 and PMID:20106945 Cux2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cux2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUX2 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CUX2 promoter] CTD PMID:17942748 and PMID:19654925 Cux2 Rat 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO CUX2 (Homo sapiens) 6480464 3 more ... CTD PMID:19692669 Cux2 Rat 4,4'-sulfonyldiphenol decreases methylation ISO Cux2 (Mus musculus) 6480464 bisphenol S results in decreased methylation of CUX2 exon CTD PMID:33297965 Cux2 Rat 4,4'-sulfonyldiphenol decreases methylation ISO CUX2 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of CUX2 gene CTD PMID:31601247 Cux2 Rat 4,4'-sulfonyldiphenol decreases expression ISO Cux2 (Mus musculus) 6480464 bisphenol S results in decreased expression of CUX2 mRNA CTD PMID:39298647 Cux2 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CUX2 mRNA CTD PMID:30047161 Cux2 Rat 8-Br-cAMP decreases expression ISO CUX2 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CUX2 mRNA CTD PMID:22079614 Cux2 Rat acrylamide decreases expression ISO CUX2 (Homo sapiens) 6480464 Acrylamide results in decreased expression of CUX2 mRNA CTD PMID:32763439 Cux2 Rat aflatoxin B1 affects expression ISO CUX2 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of CUX2 protein CTD PMID:20106945 Cux2 Rat aflatoxin B1 increases methylation ISO CUX2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of CUX2 intron CTD PMID:30157460 Cux2 Rat aflatoxin B1 decreases methylation ISO CUX2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CUX2 gene CTD PMID:27153756 Cux2 Rat Aflatoxin B2 alpha decreases methylation ISO CUX2 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of CUX2 intron CTD PMID:30157460 Cux2 Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of CUX2 mRNA CTD PMID:30047161 Cux2 Rat arsane multiple interactions ISO CUX2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CUX2 mRNA CTD PMID:32525701 Cux2 Rat arsane affects methylation ISO CUX2 (Homo sapiens) 6480464 Arsenic affects the methylation of CUX2 gene CTD PMID:25304211 Cux2 Rat arsenic atom affects methylation ISO CUX2 (Homo sapiens) 6480464 Arsenic affects the methylation of CUX2 gene CTD PMID:25304211 Cux2 Rat arsenic atom multiple interactions ISO CUX2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CUX2 mRNA CTD PMID:32525701 Cux2 Rat atrazine decreases expression ISO CUX2 (Homo sapiens) 6480464 Atrazine results in decreased expression of CUX2 mRNA CTD PMID:22378314 Cux2 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of CUX2 gene CTD PMID:35440735 Cux2 Rat azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA CTD PMID:33854195 Cux2 Rat benzo[a]pyrene decreases expression ISO CUX2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CUX2 mRNA CTD PMID:20106945 and PMID:32234424 Cux2 Rat benzo[a]pyrene affects methylation ISO CUX2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CUX2 intron CTD PMID:30157460 Cux2 Rat benzo[a]pyrene increases methylation ISO CUX2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CUX2 promoter CTD PMID:27901495 Cux2 Rat benzo[a]pyrene decreases methylation ISO Cux2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of CUX2 intron CTD PMID:27901495 Cux2 Rat benzo[e]pyrene increases methylation ISO CUX2 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of CUX2 intron CTD PMID:30157460 Cux2 Rat bis(2-chloroethyl) sulfide increases expression ISO Cux2 (Mus musculus) 6480464 Mustard Gas results in increased expression of CUX2 mRNA CTD PMID:15674843 Cux2 Rat bis(2-ethylhexyl) phthalate decreases expression ISO CUX2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of CUX2 mRNA CTD PMID:31163220 Cux2 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Cux2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of CUX2 mRNA CTD PMID:34319233 Cux2 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CUX2 gene CTD PMID:28505145 Cux2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CUX2 mRNA CTD PMID:32145629 and PMID:35192832 Cux2 Rat bisphenol A decreases methylation ISO CUX2 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of CUX2 gene CTD PMID:31601247 Cux2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CUX2 mRNA CTD PMID:30816183 Cux2 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of CUX2 gene CTD PMID:28505145 Cux2 Rat bisphenol A affects methylation ISO Cux2 (Mus musculus) 6480464 bisphenol A affects the methylation of CUX2 promoter CTD PMID:27334623 Cux2 Rat bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of CUX2 mRNA CTD PMID:32479839 Cux2 Rat carbon nanotube decreases expression ISO Cux2 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of CUX2 mRNA CTD PMID:25620056 Cux2 Rat carmustine affects expression EXP 6480464 Carmustine affects the expression of CUX2 mRNA CTD PMID:19174181 Cux2 Rat chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA CTD PMID:33854195 Cux2 Rat clobetasol decreases expression ISO Cux2 (Mus musculus) 6480464 Clobetasol results in decreased expression of CUX2 mRNA CTD PMID:27462272 Cux2 Rat crocidolite asbestos decreases expression ISO Cux2 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of CUX2 mRNA CTD PMID:19446018 Cux2 Rat cyclosporin A decreases expression ISO CUX2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CUX2 mRNA CTD PMID:20106945 and PMID:27989131 Cux2 Rat diazinon increases methylation ISO CUX2 (Homo sapiens) 6480464 Diazinon results in increased methylation of CUX2 gene CTD PMID:22964155 Cux2 Rat dibutyl phthalate increases expression ISO Cux2 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of CUX2 mRNA CTD PMID:21266533 Cux2 Rat dichloromethane decreases expression ISO Cux2 (Mus musculus) 6480464 Methylene Chloride results in decreased expression of CUX2 mRNA CTD PMID:28392392 Cux2 Rat dorsomorphin multiple interactions ISO CUX2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Cux2 Rat doxorubicin increases expression ISO CUX2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of CUX2 mRNA CTD PMID:29803840 Cux2 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CUX2 mRNA CTD PMID:29391264 Cux2 Rat epoxiconazole affects expression ISO Cux2 (Mus musculus) 6480464 epoxiconazole affects the expression of CUX2 mRNA CTD PMID:35436446 Cux2 Rat folic acid decreases expression ISO Cux2 (Mus musculus) 6480464 Folic Acid results in decreased expression of CUX2 mRNA CTD PMID:25629700 Cux2 Rat fulvestrant increases methylation ISO CUX2 (Homo sapiens) 6480464 Fulvestrant results in increased methylation of CUX2 gene CTD PMID:31601247 Cux2 Rat genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of CUX2 gene CTD PMID:28505145 Cux2 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CUX2 mRNA CTD PMID:22061828 Cux2 Rat glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA CTD PMID:33854195 Cux2 Rat glyphosate affects methylation EXP 6480464 Glyphosate affects the methylation of CUX2 gene CTD PMID:35440735 Cux2 Rat imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA CTD PMID:33854195 Cux2 Rat indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA more ... CTD PMID:22129741 Cux2 Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of CUX2 mRNA CTD PMID:21396975 Cux2 Rat iron dichloride decreases expression ISO CUX2 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of CUX2 mRNA CTD PMID:35984750 Cux2 Rat isoprenaline decreases expression ISO Cux2 (Mus musculus) 6480464 Isoproterenol results in decreased expression of CUX2 mRNA CTD PMID:20003209 Cux2 Rat isotretinoin decreases expression ISO CUX2 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of CUX2 mRNA CTD PMID:20436886 Cux2 Rat lead nitrate multiple interactions ISO Cux2 (Mus musculus) 6480464 lead nitrate affects the reaction [CUX2 affects the expression of MT1 mRNA] and lead nitrate affects the reaction [CUX2 affects the expression of MT2 mRNA] CTD PMID:11891201 Cux2 Rat lipopolysaccharide increases expression ISO Cux2 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of CUX2 mRNA CTD PMID:12057914 Cux2 Rat lipopolysaccharide decreases expression ISO CUX2 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of CUX2 mRNA CTD PMID:35811015 Cux2 Rat lipopolysaccharide multiple interactions ISO CUX2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CUX2 mRNA CTD PMID:35811015 Cux2 Rat methapyrilene increases methylation ISO CUX2 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of CUX2 intron CTD PMID:30157460 Cux2 Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of CUX2 mRNA CTD PMID:30047161 Cux2 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of CUX2 gene CTD PMID:35440735 Cux2 Rat methylmercury chloride decreases expression ISO CUX2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of CUX2 mRNA CTD PMID:28001369 Cux2 Rat morphine increases expression ISO Cux2 (Mus musculus) 6480464 Morphine results in increased expression of CUX2 mRNA CTD PMID:21178816 Cux2 Rat N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA and Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA] CTD PMID:22129741 Cux2 Rat N-ethyl-N-nitrosourea increases mutagenesis ISO Cux2 (Mus musculus) 6480464 Ethylnitrosourea results in increased mutagenesis of CUX2 intron CTD PMID:27776689 Cux2 Rat N-methyl-4-phenylpyridinium decreases expression ISO CUX2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CUX2 mRNA CTD PMID:24810058 Cux2 Rat N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CUX2 mRNA CTD PMID:28801915 Cux2 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA more ... CTD PMID:22129741 Cux2 Rat nevirapine decreases expression EXP 6480464 Nevirapine metabolite results in decreased expression of CUX2 mRNA CTD PMID:23947594 Cux2 Rat O-methyleugenol decreases expression ISO CUX2 (Homo sapiens) 6480464 methyleugenol results in decreased expression of CUX2 mRNA CTD PMID:32234424 Cux2 Rat paracetamol decreases expression ISO CUX2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CUX2 mRNA CTD PMID:29067470 Cux2 Rat pentachlorophenol increases expression ISO Cux2 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of CUX2 mRNA CTD PMID:23892564 Cux2 Rat phenobarbital affects expression ISO CUX2 (Homo sapiens) 6480464 Phenobarbital affects the expression of CUX2 mRNA CTD PMID:19159669 Cux2 Rat pirinixic acid multiple interactions ISO CUX2 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CUX2 mRNA CTD PMID:19710929 Cux2 Rat pirinixic acid decreases expression ISO Cux2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of CUX2 mRNA CTD PMID:20813756 and PMID:23811191 Cux2 Rat progesterone multiple interactions ISO CUX2 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in increased expression of CUX2 mRNA CTD PMID:17404688 Cux2 Rat progesterone increases expression ISO CUX2 (Homo sapiens) 6480464 Progesterone results in increased expression of CUX2 mRNA CTD PMID:17404688 Cux2 Rat progesterone decreases expression ISO CUX2 (Homo sapiens) 6480464 Progesterone results in decreased expression of CUX2 mRNA CTD PMID:18070364 Cux2 Rat quercetin increases expression EXP 6480464 Quercetin results in increased expression of CUX2 mRNA CTD PMID:21565894 Cux2 Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of CUX2 mRNA CTD PMID:28374803 Cux2 Rat rotenone decreases expression ISO CUX2 (Homo sapiens) 6480464 Rotenone results in decreased expression of CUX2 mRNA CTD PMID:29955902 Cux2 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO CUX2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CUX2 mRNA CTD PMID:35811015 Cux2 Rat SB 431542 multiple interactions ISO CUX2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Cux2 Rat sodium arsenate multiple interactions ISO CUX2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CUX2 mRNA CTD PMID:32525701 Cux2 Rat sodium arsenite decreases expression ISO CUX2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CUX2 mRNA CTD PMID:29301061 Cux2 Rat sodium arsenite increases expression ISO Cux2 (Mus musculus) 6480464 sodium arsenite results in increased expression of CUX2 mRNA CTD PMID:37682722 Cux2 Rat sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of CUX2 mRNA CTD PMID:30047161 Cux2 Rat tamoxifen decreases expression ISO Cux2 (Mus musculus) 6480464 Tamoxifen results in decreased expression of CUX2 mRNA CTD PMID:25123088 Cux2 Rat tamoxifen increases expression ISO Cux2 (Mus musculus) 6480464 Tamoxifen results in increased expression of CUX2 mRNA CTD PMID:17555576 Cux2 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CUX2 mRNA CTD PMID:31150632 Cux2 Rat thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA CTD PMID:33854195 Cux2 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CUX2 mRNA CTD PMID:34492290 Cux2 Rat titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CUX2 mRNA CTD PMID:30012374 Cux2 Rat titanium dioxide increases methylation ISO Cux2 (Mus musculus) 6480464 titanium dioxide results in increased methylation of CUX2 promoter CTD PMID:35295148 Cux2 Rat titanium dioxide decreases methylation ISO Cux2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of CUX2 gene CTD PMID:35295148 Cux2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CUX2 mRNA CTD PMID:33387578 Cux2 Rat trichostatin A increases expression ISO CUX2 (Homo sapiens) 6480464 trichostatin A results in increased expression of CUX2 mRNA CTD PMID:24935251 Cux2 Rat trichostatin A multiple interactions ISO CUX2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX2 mRNA CTD PMID:27188386 Cux2 Rat trichostatin A decreases expression ISO CUX2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of CUX2 mRNA CTD PMID:24935251 and PMID:26272509 Cux2 Rat triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CUX2 mRNA CTD PMID:30589522 Cux2 Rat triptonide increases expression ISO Cux2 (Mus musculus) 6480464 triptonide results in increased expression of CUX2 mRNA CTD PMID:33045310 Cux2 Rat trovafloxacin increases expression ISO Cux2 (Mus musculus) 6480464 trovafloxacin results in increased expression of CUX2 mRNA CTD PMID:35537566 Cux2 Rat valproic acid affects expression ISO Cux2 (Mus musculus) 6480464 Valproic Acid affects the expression of CUX2 mRNA CTD PMID:17963808 Cux2 Rat valproic acid affects expression ISO CUX2 (Homo sapiens) 6480464 Valproic Acid affects the expression of CUX2 mRNA CTD PMID:25979313 Cux2 Rat valproic acid decreases expression ISO CUX2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CUX2 mRNA CTD PMID:23179753 more ... Cux2 Rat valproic acid multiple interactions ISO CUX2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX2 mRNA CTD PMID:27188386 Cux2 Rat valproic acid increases expression ISO CUX2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CUX2 mRNA CTD PMID:23179753 more ...
17alpha-ethynylestradiol (ISO) 17beta-estradiol (EXP,ISO) 17beta-hydroxy-5alpha-androstan-3-one (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 3,3',4,4',5-pentachlorobiphenyl (ISO) 4,4'-sulfonyldiphenol (ISO) 6-propyl-2-thiouracil (EXP) 8-Br-cAMP (ISO) acrylamide (ISO) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) amitrole (EXP) arsane (ISO) arsenic atom (ISO) atrazine (EXP,ISO) azoxystrobin (EXP) benzo[a]pyrene (ISO) benzo[e]pyrene (ISO) bis(2-chloroethyl) sulfide (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bromobenzene (EXP) carbon nanotube (ISO) carmustine (EXP) chlorpyrifos (EXP) clobetasol (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) diazinon (ISO) dibutyl phthalate (ISO) dichloromethane (ISO) dorsomorphin (ISO) doxorubicin (ISO) endosulfan (EXP) epoxiconazole (ISO) folic acid (ISO) fulvestrant (ISO) genistein (EXP) gentamycin (EXP) glyphosate (EXP) imidacloprid (EXP) indole-3-methanol (EXP) iron dichloride (ISO) isoprenaline (ISO) isotretinoin (ISO) lead nitrate (ISO) lipopolysaccharide (ISO) methapyrilene (ISO) methimazole (EXP) methoxychlor (EXP) methylmercury chloride (ISO) morphine (ISO) N-acetyl-L-cysteine (EXP) N-ethyl-N-nitrosourea (ISO) N-methyl-4-phenylpyridinium (EXP,ISO) N-nitrosodiethylamine (EXP) nevirapine (EXP) O-methyleugenol (ISO) paracetamol (ISO) pentachlorophenol (ISO) phenobarbital (ISO) pirinixic acid (ISO) progesterone (ISO) quercetin (EXP) rotenone (EXP,ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) sodium arsenate (ISO) sodium arsenite (ISO) sulfadimethoxine (EXP) tamoxifen (ISO) tetrachloromethane (EXP) thiabendazole (EXP) thioacetamide (EXP) titanium dioxide (EXP,ISO) trichloroethene (EXP) trichostatin A (ISO) triphenyl phosphate (EXP) triptonide (ISO) trovafloxacin (ISO) valproic acid (ISO)
Cux2 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 12 40,168,402 - 40,368,303 (+) NCBI GRCr8 mRatBN7.2 12 34,507,723 - 34,707,581 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 12 34,520,959 - 34,705,806 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 12 35,693,412 - 35,878,823 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 12 36,304,624 - 36,490,037 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 12 35,357,113 - 35,542,505 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 12 40,016,774 - 40,221,067 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 12 40,018,937 - 40,219,291 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 12 41,893,143 - 42,092,024 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 12 35,850,093 - 35,910,414 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 12 35,727,879 - 35,773,518 (+) NCBI Celera 12 36,188,363 - 36,371,360 (+) NCBI Celera Cytogenetic Map 12 q16 NCBI
CUX2 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 12 111,034,165 - 111,350,554 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 12 111,034,165 - 111,350,554 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 12 111,471,969 - 111,788,358 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 12 109,956,212 - 110,272,739 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 12 109,934,548 - 110,251,076 NCBI Celera 12 111,098,413 - 111,414,529 (+) NCBI Celera Cytogenetic Map 12 q24.11-q24.12 NCBI HuRef 12 108,667,813 - 108,803,094 (+) NCBI HuRef CHM1_1 12 111,439,881 - 111,756,318 (+) NCBI CHM1_1 T2T-CHM13v2.0 12 111,013,350 - 111,331,050 (+) NCBI T2T-CHM13v2.0
Cux2 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 5 121,996,025 - 122,188,522 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 5 121,994,429 - 122,188,165 (-) Ensembl GRCm39 Ensembl GRCm38 5 121,857,962 - 122,050,415 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 5 121,856,366 - 122,050,102 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 5 122,310,225 - 122,497,834 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 5 122,120,833 - 122,308,442 (-) NCBI MGSCv36 mm8 Celera 5 118,950,598 - 119,138,874 (-) NCBI Celera Cytogenetic Map 5 F NCBI cM Map 5 62.02 NCBI
Cux2 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955482 7,955,039 - 8,043,533 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955482 7,783,483 - 8,045,808 (+) NCBI ChiLan1.0 ChiLan1.0
CUX2 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 10 119,094,013 - 119,417,278 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 12 119,090,421 - 119,465,960 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 12 108,600,286 - 108,975,588 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 12 112,143,682 - 112,313,451 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 12 112,175,555 - 112,311,221 (+) Ensembl panpan1.1 panPan2
CUX2 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 26 8,711,816 - 8,997,263 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 26 8,730,435 - 8,993,205 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 26 8,874,945 - 9,160,037 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 26 8,971,508 - 9,256,848 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 26 8,990,189 - 9,255,070 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 26 8,928,111 - 9,212,941 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 26 8,990,069 - 9,275,112 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 26 8,943,481 - 9,228,574 (+) NCBI UU_Cfam_GSD_1.0
Cux2
CUX2 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 14 32,311,188 - 32,587,203 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 14 32,311,781 - 32,587,194 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 14 34,262,426 - 34,582,740 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
CUX2
Cux2
.
Predicted Target Of
Count of predictions: 92 Count of miRNA genes: 85 Interacting mature miRNAs: 89 Transcripts: ENSRNOT00000001697 Prediction methods: Microtar, Rnahybrid, Targetscan Result types: miRGate_prediction
631560 Apr1 Acute phase response QTL 1 6.1 orosomucoid 1 amount (VT:0010541) plasma orosomucoid 1 level (CMO:0001467) 12 19144362 46669029 Rat 8552964 Pigfal17 Plasma insulin-like growth factor 1 level QTL 17 3.5 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564495 46669029 Rat 8693635 Alc28 Alcohol consumption QTL 28 2.7 0.439 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 12 23081340 44726024 Rat 61324 Eae5 Experimental allergic encephalomyelitis QTL 5 14 nervous system integrity trait (VT:0010566) percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time (CMO:0001402) 12 19610870 46669029 Rat 9590147 Scort7 Serum corticosterone level QTL 7 13.61 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 12 1 42110980 Rat 1549829 Scl48 Serum cholesterol level QTL 48 5 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 12 9603277 46669029 Rat 737822 Alc10 Alcohol consumption QTL 10 2.2 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 12 19610870 40218516 Rat 70169 Eae13 Experimental allergic encephalomyelitis QTL 13 0.032 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 12 24139202 36638073 Rat 1600386 Calcic2 Intracellular calcium level QTL 2 0.001 platelet physiology trait (VT:0005464) platelet intracellular calcium level (CMO:0000922) 12 28064433 46669029 Rat 1302792 Scl21 Serum cholesterol level QTL 21 3.8 0.0011 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 12 7196730 46669029 Rat 1556747 Calcic1 Intracellular calcium level QTL 1 3.6 platelet calcium amount (VT:0010500) platelet intracellular calcium level (CMO:0000922) 12 28064433 40130419 Rat 631829 Alc6 Alcohol consumption QTL 6 4.7 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 12 28607526 37691617 Rat 8693658 Alc33 Alcohol consumption QTL 33 2.1 0.68 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 12 23081340 43551788 Rat 1598855 Bp294 Blood pressure QTL 294 3.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 1 34851688 Rat 1331761 Bp218 Blood pressure QTL 218 2.973 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 12 11073825 45055165 Rat 8694179 Bw150 Body weight QTL 150 2.9 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 12 1 42110980 Rat 7411545 Bw128 Body weight QTL 128 5.2 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 12 1 42110980 Rat 7411547 Bw129 Body weight QTL 129 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 6 5564495 46669029 Rat 737979 Pia22 Pristane induced arthritis QTL 22 53.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 1 44465750 Rat 1298081 Cia25 Collagen induced arthritis QTL 25 4.7 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 19610889 35682913 Rat 2300186 Bmd59 Bone mineral density QTL 59 7.1 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 12 10474137 46669029 Rat 7411660 Foco28 Food consumption QTL 28 10.9 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 70213 Niddm27 Non-insulin dependent diabetes mellitus QTL 27 3.72 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 19835789 38193007 Rat 7411641 Foco19 Food consumption QTL 19 27.7 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 7411643 Foco20 Food consumption QTL 20 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 20328819 46669029 Rat 5684888 Pia42 Pristane induced arthritis QTL 42 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 19610870 42828880 Rat 1549912 Bp268 Blood pressure QTL 268 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 13182736 46669029 Rat 2302060 Pia37 Pristane induced arthritis QTL 37 6.1 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 12 13198157 46669029 Rat 1641928 Alcrsp5 Alcohol response QTL 5 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 12 12812385 46669029 Rat 1300162 Bp188 Blood pressure QTL 188 3.19 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 32103174 45899022 Rat 8552912 Pigfal6 Plasma insulin-like growth factor 1 level QTL 6 5 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564498 46669029 Rat 10059594 Kidm46 Kidney mass QTL 46 3.79 0.025 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 12 6107579 46669029 Rat 9590086 Insglur6 Insulin/glucose ratio QTL 6 18.97 0.001 blood insulin amount (VT:0001560) calculated plasma insulin level (CMO:0002170) 12 1 42110980 Rat 8552918 Pigfal7 Plasma insulin-like growth factor 1 level QTL 7 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564495 46669029 Rat 1549902 Bp269 Blood pressure QTL 269 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 13182736 46669029 Rat 61404 Bw120 Body weight QTL 120 5.1 body mass (VT:0001259) body mass index (BMI) (CMO:0000105) 12 12351619 46669029 Rat 1300175 Cm5 Cardiac mass QTL 5 3.78 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 12 28064433 45899022 Rat 1331787 Rf41 Renal function QTL 41 2.998 kidney blood vessel physiology trait (VT:0100012) absolute change in renal blood flow rate (CMO:0001168) 12 28064557 40218380 Rat 2293699 Bss49 Bone structure and strength QTL 49 5.61 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra trabecular cross-sectional area (CMO:0001692) 12 10474137 46669029 Rat 634351 Apr5 Acute phase response QTL 5 6.7 blood interleukin-6 amount (VT:0008595) plasma interleukin-6 level (CMO:0001927) 12 1 44503507 Rat 634350 Apr4 Acute phase response QTL 4 6 orosomucoid 1 amount (VT:0010541) plasma orosomucoid 1 level (CMO:0001467) 12 1172005 46172005 Rat 7387292 Kidm42 Kidney mass QTL 42 3.03 0.0004 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 12 1 36247923 Rat 61421 Cia12 Collagen induced arthritis QTL 12 4.6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 13635523 35682913 Rat 2303569 Gluco44 Glucose level QTL 44 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 12812385 46669029 Rat 7411586 Foco5 Food consumption QTL 5 5.4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 2303575 Insul14 Insulin level QTL 14 4 blood insulin amount (VT:0001560) blood insulin level (CMO:0000349) 12 1 42450532 Rat 7411588 Foco6 Food consumption QTL 6 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 2302042 Pia38 Pristane induced arthritis QTL 38 3.5 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 12 1 44503507 Rat 7411595 Foco9 Food consumption QTL 9 4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 7411597 Foco10 Food consumption QTL 10 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 631543 Bp83 Blood pressure QTL 83 5.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 15550826 38478808 Rat
D12Rat18
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 12 34,702,426 - 34,702,587 (+) MAPPER mRatBN7.2 Rnor_6.0 12 40,215,912 - 40,216,072 NCBI Rnor6.0 Rnor_5.0 12 42,086,869 - 42,087,029 UniSTS Rnor5.0 RGSC_v3.4 12 35,907,119 - 35,907,279 UniSTS RGSC3.4 RGSC_v3.4 12 35,907,118 - 35,907,279 RGD RGSC3.4 RGSC_v3.1 12 35,770,507 - 35,770,667 RGD Celera 12 36,367,985 - 36,368,141 UniSTS RH 3.4 Map 12 618.7 RGD RH 3.4 Map 12 618.7 UniSTS RH 2.0 Map 12 465.7 RGD FHH x ACI Map 12 35.52 RGD Cytogenetic Map 12 q16 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
10
49
113
91
90
59
25
59
6
217
96
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000001697 ⟹ ENSRNOP00000001697
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 34,520,959 - 34,705,806 (+) Ensembl Rnor_6.0 Ensembl 12 40,018,937 - 40,219,291 (+) Ensembl
RefSeq Acc Id:
NM_001271380 ⟹ NP_001258309
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,181,688 - 40,366,528 (+) NCBI mRatBN7.2 12 34,520,959 - 34,705,806 (+) NCBI Rnor_6.0 12 40,018,937 - 40,219,291 (+) NCBI Rnor_5.0 12 41,893,143 - 42,092,024 (+) NCBI Celera 12 36,188,363 - 36,371,360 (+) NCBI
Sequence:
TGACTGTGGAAGCTGCTGCACGGGACCTTCCAGGCCTAGGCTGGTGCAGCTGCCCACTCTCTGCCCCCGCCTCAGACTCTCCTGTGGTCCCTTGCACAGTGTGCAAAGCCCAGGGTCTTCCAGACATC
hide sequence
RefSeq Acc Id:
NM_001415781 ⟹ NP_001402710
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,179,282 - 40,366,528 (+) NCBI mRatBN7.2 12 34,518,551 - 34,705,806 (+) NCBI
RefSeq Acc Id:
XM_039089246 ⟹ XP_038945174
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,179,068 - 40,368,303 (+) NCBI mRatBN7.2 12 34,518,333 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089247 ⟹ XP_038945175
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,179,067 - 40,368,303 (+) NCBI mRatBN7.2 12 34,518,333 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089248 ⟹ XP_038945176
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,179,068 - 40,368,303 (+) NCBI mRatBN7.2 12 34,518,333 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089249 ⟹ XP_038945177
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,179,069 - 40,368,303 (+) NCBI mRatBN7.2 12 34,518,334 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089251 ⟹ XP_038945179
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,295,468 - 40,368,303 (+) NCBI mRatBN7.2 12 34,634,880 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089252 ⟹ XP_038945180
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,179,361 - 40,368,303 (+) NCBI mRatBN7.2 12 34,518,333 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089253 ⟹ XP_038945181
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,179,659 - 40,368,303 (+) NCBI mRatBN7.2 12 34,518,881 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089254 ⟹ XP_038945182
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,168,402 - 40,368,303 (+) NCBI mRatBN7.2 12 34,507,723 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089255 ⟹ XP_038945183
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,179,361 - 40,368,303 (+) NCBI mRatBN7.2 12 34,518,333 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089256 ⟹ XP_038945184
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,168,402 - 40,368,303 (+) NCBI mRatBN7.2 12 34,507,723 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089257 ⟹ XP_038945185
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,168,402 - 40,368,303 (+) NCBI mRatBN7.2 12 34,507,723 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089259 ⟹ XP_038945187
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,257,235 - 40,368,303 (+) NCBI mRatBN7.2 12 34,588,329 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089260 ⟹ XP_038945188
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,204,618 - 40,368,303 (+) NCBI mRatBN7.2 12 34,543,881 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089261 ⟹ XP_038945189
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,179,511 - 40,368,303 (+) NCBI mRatBN7.2 12 34,518,779 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089262 ⟹ XP_038945190
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,224,283 - 40,368,303 (+) NCBI mRatBN7.2 12 34,563,546 - 34,707,581 (+) NCBI
RefSeq Acc Id:
XM_039089263 ⟹ XP_038945191
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 40,209,056 - 40,368,303 (+) NCBI mRatBN7.2 12 34,548,440 - 34,707,581 (+) NCBI
RefSeq Acc Id:
NP_001258309 ⟸ NM_001271380
- Peptide Label:
isoform 1
- UniProtKB:
F1M048 (UniProtKB/TrEMBL)
- Sequence:
MVAPVLKSFQAEVVALSKRSQEAEAAFLSVYKQLIEAPDPVPSVEVARTLDDRLQRPSFHPSGQRLRDVHISWKRCPEPPSAREQNEGTCPTGHTPANGNHLPGPEDTLVTDTLLQKDEAERQKGLQE
hide sequence
Ensembl Acc Id:
ENSRNOP00000001697 ⟸ ENSRNOT00000001697
RefSeq Acc Id:
XP_038945182 ⟸ XM_039089254
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945184 ⟸ XM_039089256
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945185 ⟸ XM_039089257
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945180 ⟸ XM_039089252
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945183 ⟸ XM_039089255
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945174 ⟸ XM_039089246
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_038945176 ⟸ XM_039089248
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_038945175 ⟸ XM_039089247
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_038945177 ⟸ XM_039089249
- Peptide Label:
isoform X4
RefSeq Acc Id:
XP_038945189 ⟸ XM_039089261
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945181 ⟸ XM_039089253
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945188 ⟸ XM_039089260
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945191 ⟸ XM_039089263
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945190 ⟸ XM_039089262
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945187 ⟸ XM_039089259
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038945179 ⟸ XM_039089251
- Peptide Label:
isoform X5
RefSeq Acc Id:
NP_001402710 ⟸ NM_001415781
- Peptide Label:
isoform 2
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2013-05-24
Cux2
cut-like homeobox 2
LOC687661
similar to cut-like 2
Data merged from RGD:1583046
1643240 APPROVED
2008-03-10
Cux2
cut-like homeobox 2
Cutl2_predicted
cut-like 2 (Drosophila) (predicted)
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2006-11-19
LOC687661
similar to cut-like 2
Symbol and Name status set to provisional
70820 PROVISIONAL
2005-01-12
Cutl2_predicted
cut-like 2 (Drosophila) (predicted)
Symbol and Name status set to approved
70820 APPROVED
